VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 71 filers reported holding VERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,123,500 | -81.8% | 70,000 | -91.2% | 0.16% | -82.4% |
| Q1 2023 | $6,169,200 | -52.1% | 795,000 | +19.5% | 0.89% | -55.7% |
| Q4 2022 | $12,870,769 | +13.3% | 665,156 | +24.7% | 2.00% | +2.2% |
| Q3 2022 | $11,364,000 | +45.2% | 533,264 | -7.3% | 1.96% | -6.1% |
| Q2 2022 | $7,826,000 | -42.1% | 575,000 | 0.0% | 2.09% | -28.5% |
| Q1 2022 | $13,507,000 | -24.7% | 575,000 | -14.3% | 2.92% | -16.3% |
| Q4 2021 | $17,928,000 | +48.4% | 670,940 | -3.6% | 3.49% | +17.3% |
| Q3 2021 | $12,078,000 | -19.5% | 696,126 | -38.5% | 2.97% | -4.3% |
| Q2 2021 | $15,008,000 | – | 1,132,671 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |